產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-IFIT1B抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-IFIT1B抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-IFIT1B
Cat. Number:
Anti-IFIT1B抗體KL-15554R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
IFIT1L is a 474 amino acid protein that belongs to the IFIT family and contains eight TPR repeats. The gene encoding IFIT1L maps to human chromosome 10q23.31. Spanning nearly 135 million base pairs, chromosome 10 makes up Anti-IFIT1B抗體approximately 4.5% of total DNA in cells and encodes nearly 1,200 genes. Several protein-coding genes, including those that encode for chemokines, cadherins, excision repair proteins, early growth response factors (Egrs) and fibroblast growth receptors (FGFRs), are located on chromosome 10. Defects in some of the genes that map to chromosome 10 are associated with Charcot-Marie Tooth disease, Jackson-Weiss syndrome, Usher syndrome, nonsyndromatic deafness, Wolman’s syndrome, Cowden syndrome, multiple endocrine neoplasia type 2 and porphyria.
Also known as:
bA149I23.6; IFIT1B; IFIT1L; IFT1B_HUMAN; Anti-IFIT1B抗體Interferon-induced protein with tetratricopeptide repeats 1-like protein; Interferon-induced protein with tetratricopeptide repeats 1B.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, .
●
Immunogen: KLH conjugated synthetic peptide derived from human IFIT1B .
●
Predicted Molecular Weight: 55kDa.Anti-IFIT1B抗體
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 Anti-IFIT1B抗體
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl364Hu01 乳腺癌易感蛋白2(BRCA2)多克隆抗體 Polyclonal Antibody to Breast Cancer Susceptibility Protein 2 (BRCA2)
kl364Mu01 乳腺癌易感蛋白2(BRCA2)多克隆抗體 Polyclonal Antibody to Breast Cancer Susceptibility Protein 2 (BRCA2)
kl365Hu01 葡萄糖激酶調(diào)節(jié)蛋白(GKRP)多克隆抗體 Polyclonal Antibody to Glucokinase Regulatory Protein (GKRP)
kl366Hu01 血管內(nèi)皮鈣黏蛋白(CDH5)多克隆抗體 Polyclonal Antibody to Cadherin 5 (CDH5)
kl366Mu01 血管內(nèi)皮鈣黏蛋白(CDH5)多克隆抗體 Polyclonal Antibody to Cadherin 5 (CDH5)
kl367Hu01 血管內(nèi)皮生長(zhǎng)因子受體2(VEGFR2)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
kl367Mu01 血管內(nèi)皮生長(zhǎng)因子受體2(VEGFR2)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
kl367Ra01 血管內(nèi)皮生長(zhǎng)因子受體2(VEGFR2)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
kl368Hu01 肝配蛋白A受體1(EPHA1)多克隆抗體 Polyclonal Antibody to Ephrin Type A Receptor 1 (EPHA1)
kl370Hu01 乳酸脫氫酶A(LDHA)多克隆抗體 Polyclonal Antibody to Lactate Dehydrogenase A (LDHA)
kl370Ra01 乳酸脫氫酶A(LDHA)多克隆抗體 Polyclonal Antibody to Lactate Dehydrogenase A (LDHA)
kl371Hu01 轉(zhuǎn)醛縮酶(TALDO1)多克隆抗體 Polyclonal Antibody to Transaldolase (TALDO1)
kl371Ra01 轉(zhuǎn)醛縮酶(TALDO1)多克隆抗體 Polyclonal Antibody to Transaldolase (TALDO1)
kl372Hu01 鱗狀細(xì)胞癌抗原1(SCCA1)多克隆抗體 Polyclonal Antibody to Squamous Cell Carcinoma Antigen 1 (SCCA1)
kl373Hu01 防御素β1(DEFβ1)多克隆抗體 Polyclonal Antibody to Defensin Beta 1 (DEFb1)
kl373Mu01 防御素β1(DEFβ1)多克隆抗體 Polyclonal Antibody to Defensin Beta 1 (DEFb1)
kl373Po01 防御素β1(DEFβ1)多克隆抗體 Polyclonal Antibody to Defensin Beta 1 (DEFb1)
